A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia

被引:37
|
作者
Shingleton, WB [1 ]
Terrell, F [1 ]
Renfroe, DL [1 ]
Kolski, JM [1 ]
Fowler, JE [1 ]
机构
[1] Univ Mississippi, Sch Med, Div Urol, Jackson, MS 39216 USA
关键词
D O I
10.1016/S0090-4295(99)00319-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives, To compare the safety and efficacy of laser ablation of the prostate, one of the minimally invasive treatments available for men with benign prostatic hyperplasia, to transurethral resection of the prostate (TURP). Methods. A prospective randomized study of 100 men with benign prostatic hyperplasia, with 50 patients in each:treatment arm, was conducted. All patients met the entry criteria: age older than 45 years, no history of carcinoma of the prostate, a peak flow rate less than 15 mL/s, medical therapy failure, and the ability to undergo regional or general anesthesia. All patients underwent a preoperative evaluation consisting of the American Urological Association (AUA) symptom score, uroflowmetry, pressure-flow study, transrectal ultrasound for prostate volume, and serum prostate-specific antigen determination. Patients underwent either TURF or laser ablation of the prostate using the potassium titanyl phosphate (KTP)/neodymium: yttrium-aluminum-garnet laser. Patients were seen for follow-up at 1, 3, 6, and 12 months. Results. The mean age was 68.2 years (range 45 to 90) for the laser group and 67.4 years (range 54 to 82) for the TURP group. The mean AUA symptom score was 22 for the laser group and 21 for the TURF group. The mean peak uroflow rate was 7.6 +/- 3.4 mL/s for the laser group and 6.5 +/- 4.0 mL/s for the TURF group. At 12 months of follow-up, the mean AUA symptom score had decreased to 7 (-69.5%) for the laser group and to 3 (-80.9%) for the TURF group. The mean peak uroflow rate increased to 15.4 mL/s (+107.8%) for the laser group and to 16.7 mL/s (+150.7%) for the TURP cohort.:Seventy-five percent of the laser group had a 50% or greater decrease in their individual AUA symptom score compared with 93% of the TURF group. Sixty-five percent of the laser cohort had a 50% or greater increase in their peak uroflow rate compared: with 75% of the TURF cohort. Conclusions. Laser prostatectomy produced improvements in the peak flow rate and symptom score similar to those produced by TURF. The patients who underwent laser treatment required a longer period to reach maximum improvement, which probably reflects the lack of:tissue debulking at the time of surgery. Further improvement in laser technology will be required to produce more immediate results. (C) 1999, Elsevier Science Inc.
引用
收藏
页码:1017 / 1021
页数:5
相关论文
共 50 条
  • [21] PRELIMINARY RESULTS OF A RANDOMIZED PROSPECTIVE STUDY COMPARING ENDOVAPORISATION OF BENIGN PROSTATIC HYPERPLASIA (KTP-80 LASER) VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP)
    Schwartz, J.
    Hauser, J.
    Fateri, F.
    Iselin, C. E.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 265 - 265
  • [22] A RANDOMIZED STUDY COMPARING VISUAL LASER-ABLATION AND TRANSURETHRAL EVAPORATION OF PROSTATE IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA
    NARAYAN, P
    TEWARI, A
    ABOSEIF, S
    EVANS, C
    JOURNAL OF UROLOGY, 1995, 154 (06): : 2083 - 2088
  • [23] Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia
    Jahnson, S
    Dalén, M
    Gustavsson, G
    Pedersen, J
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (02): : 276 - 281
  • [24] Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study
    Wang, Bohan
    Zhang, Shigeng
    Sun, Chengfang
    Du, Chuanjun
    He, Gaofei
    Wen, Jiaming
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [25] GREENLIGHT HPS 120-W LASER VAPORIZATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: A PROSPECTIVE RANDOMIZED TRIAL
    Zang, Yachen
    Shan, Yuxi
    Xue, Boxin
    Yang, Dongrong
    Sun, Chuanyang
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A318 - A318
  • [26] GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A prospective randomized trial
    Xue, Boxin
    Zang, Yachen
    Zhang, Yuanyuan
    Yang, Dongrong
    Gao, Jie
    Sun, Chuanyang
    Cui, Yong
    Zhu, Jin
    Liu, Xiaolong
    Shan, Yuxi
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2013, 21 (01) : 125 - 132
  • [27] A prospective randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy alone
    Planz, B
    Kalem, T
    Sprenger, C
    Deix, T
    Djavan, B
    Hanke, P
    UROLOGIA INTERNATIONALIS, 2003, 71 (01) : 26 - 30
  • [28] Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial
    Hill, B
    Belville, W
    Bruskewitz, R
    Issa, M
    Perez-Marrero, R
    Roehrborn, C
    Terris, M
    Naslund, M
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2336 - 2340
  • [29] A prospective, randomized clinical trial comparing bipolar plasma kinetic resection of the prostate versus conventional monopolar transurethral resection of the prostate in the treatment of benign prostatic hyperplasia
    Kong, Christopher Ho Chee
    Ibrahim, M. Fadzli
    Zainuddin, Zulkifli Md
    ANNALS OF SAUDI MEDICINE, 2009, 29 (06) : 429 - 432
  • [30] Differences in stress response between patients undergoing transurethral resection versus endoscopic laser ablation of the prostate for benign prostatic hyperplasia
    Goran Bedalov
    Zeljko Bartolin
    Damir Puskar
    Ivan Savić
    Ivana Bedalov
    Marija Rudolf
    Drago Batinić
    Lasers in Medical Science, 2008, 23 : 65 - 70